Cryo-Cell International, Inc. (CCEL) — Financial statements
Income statement, balance sheet, and cash flow for Cryo-Cell International, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 32↓1.3% | 32↑2.0% | 31↑3.3% | 30↑5.0% | 29 | |
| Cost of Revenue | 7↓7.2% | 8↓5.9% | 8↓4.0% | 9↓2.2% | 9 | |
| Gross Profit | 24↑0.6% | 24↑5.0% | 23↑6.3% | 22↑8.3% | 20 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.38↓69.7% | 1↑6.1% | 1↑204.4% | 0.38↑671.6% | 0.05 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 18↓1.6% | 19↑8.2% | 17↑9.9% | 16↑6.5% | 15 | |
| Other Expenses | 5↑543.4% | 0.79↓95.3% | 17↑988.1% | 2↑27.8% | 1 | |
| Operating Expenses | 24↑15.3% | 21↓41.7% | 35↑101.2% | 18↑10.3% | 16 | |
| Total Costs & Expenses | 31↑9.0% | 29↓34.7% | 44↑65.9% | 26↑5.8% | 25 | |
| Operating Results | ||||||
| Operating Income | 0.48↓86.1% | 3↑128.3% | -12↓405.7% | 4↑0.2% | 4 | |
| Depreciation & Amortization | 0.75↑55.4% | 0.48↓71.7% | 2↓5.5% | 2↑36.4% | 1 | |
| EBITDA | 0.48↓66.2% | 1↑113.7% | -10↓256.6% | 7↑25.1% | 5 | |
| EBIT | -0.27↓128.8% | 0.94↑107.7% | -12↓350.5% | 5↑21.3% | 4 | |
| Interest & Other Income | ||||||
| Net Interest Income | -2↓10.8% | -2↓50.8% | -1↑18.7% | -2↓10.4% | -1 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 2↑10.8% | 2↑50.8% | 1↓18.7% | 2↑10.4% | 1 | |
| Non-Operating Income | 0.75↓70.4% | 3↑1541.0% | -0.18↑78.4% | -0.82↓3007.3% | 0.03 | |
| Other Income / Expenses | -3↓317.0% | -0.68↑36.2% | -1↓50.3% | -0.71↑49.9% | -1 | |
| Income Before Tax | -2↓183.3% | 3↑121.0% | -13↓502.7% | 3↑27.1% | 3 | |
| Income Tax Expense | 0.09↓96.2% | 2↑162.5% | -4↓801.8% | 0.55↑3.8% | 0.53 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -2↓704.2% | 0.40↑104.2% | -10↓443.6% | 3↑33.0% | 2 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -2↓704.2% | 0.40↑104.2% | -10↓443.6% | 3↑33.0% | 2 | |
| Bottom-Line Net Income | -2↓704.2% | 0.40↑104.2% | -10↓443.6% | 3↑33.0% | 2 | |
| EPS (Basic) | -0.30↓700.0% | 0.05↑104.4% | -1.14↓445.5% | 0.33↑26.9% | 0.26 | |
| EPS (Diluted) | -0.30↓700.0% | 0.05↑104.4% | -1.14↓445.5% | 0.33↑32.0% | 0.25 | |
| Weighted Average Shares | 8↓0.8% | 8↓2.5% | 8↓1.5% | 8↑4.0% | 8 | |
| Weighted Average Diluted Shares | 8↓1.8% | 8↓1.5% | 8↓1.7% | 8↑1.5% | 8 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.